The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

A reconsideration of the relation of ventricular enlargement to duration of illness in schizophrenia

Published Online:https://doi.org/10.1176/ajp.140.12.1564

The size of the ventricles of 19 young hospitalized patients with chronic schizophrenia was compared with that of 29 same-age control subjects. The patients had a slightly but significantly larger bicaudate ratio. Analysis of these results in the context of previous studies of ventricular size and schizophrenia suggests that, contrary to current views, there is a direct relationship between size of ventricles and duration of schizophrenic illness. The authors argue that the conflicting results of different studies of ventricular size and schizophrenia can be reconciled by postulating that both clinical schizophrenia and ventricular enlargement are overt signs of an underlying neuronal degeneration that is hereditary and progressive.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.